NovoCure's Q1 beat, Optune Lua momentum, and global expansion signal strong growth ahead. Find out why NVCR stock is a buy.

Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...

The man had kidney failure and started dialysis three days a week around the time his pain began. He was sure the dialysis ...

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Q4 2025 Earnings Call Transcript May 15, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.38, expectations ...

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...

Charted data contained the following information: general information, study characteristics ... Additional initiatives focused on improving patient flow through criteria-led discharges (discharging ...

Discover how ballistic gradients, vacuum jacketed columns, and advanced MS technology work together to boost lipidomic ...